A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis

Clinical trial NCT00097188 · COMPLETED

Trial details

NCT number: NCT00097188
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2004-12-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.